Research powered investment banking
Home
Research
Companies
Themes
Top Picks
Transactions
Events
Redeye
At a Glance
Our Culture
Research & Ratings
Investor Services
Corporate Broking
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
Posts
Investor Scoring
sign in
Member sign in
Join redeye
Home
research
Companies
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Research & Ratings
Investor Services
Corporate Broking
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
community
Posts
Investor Scoring
The latest from Redeye about Scandinavian Life Science and Technology companies
IMINT Image Intelligence
OPPO finally landed
Mytaste Group
Promising start of new M&A phase
Orexo
Zubsolv Rx data and estimate update
Calliditas Therapeutics
Additional details and data from competitor
Net Insight
Comment on yesterday’s presented measures
Isofol Medical
New results from the CC-005 trial
Mycronic
Inget vakuum på utbytesmarknaden
Sivers IMA
New design win
Gapwaves
Videointervju med vd Lars-Inge Sjöqvist
Premium
Top Picks
Ökar i fjolårsvinnare
Hansa Biopharma
Hansa Medical: Möten med EMA/FDA ger uppdaterad förväntansbild
PledPharma
Uppnår signifikant milstolpsbetalning
Nitro Games
No Superstar in sight
Stillfront Group
Strong user data, trend shift confirmed
Events
22
Jan
Fight Cancer Seminar
29
Jan
Early Bird
29
Jan
Smart Cities Seminar 2019
29
Jan
Funcom: Live presentation
12
Feb
Early Bird
21
Feb
Investor After Work Göteborg
Announcements
Redeye söker Jr Redaktör
Redeye söker Projektledare inom Corporate Finance
Redeye sponsrar integrationsprojektet Näringslivet Möter Förorten